Blog Posts in June, 2011
Posted on Jun 14, 2011 By Jennifer Williams, Esq.
The Food and Drug Administration announced June 9, 2011 that the "Warnings and Precautions" section of labeling for the 5-alpha reductase inhibitor (5-ARI) class of drugs has been revised to include ...
Continue reading "Proscar, Propecia, Avodart and Jalyn Get New Prostate Cancer Warnings" »
Posted on Jun 13, 2011 By Jennifer Williams, Esq.
The French medicines agency (AFSSPS) has suspended the use of the diabetes drug Actos until a European safety review has been conducted. Actos is manufactured by Takeda Pharmaceuticals and the current ...
Continue reading "Actos Use Suspended in France on Bladder Cancer Fears" »
Posted on Jun 9, 2011 By Jennifer Williams, Esq.
Yesterday the U.S. Food and Drug Administration announced label changes for the cholesterol-lowering medication simvastatin. THe FDA warned that the highest approved dose--80 mg--has been associated ...
Continue reading "FDA Announces New Safety Information for High-Dose Simvastatin" »